Novo Nordisk slides while Moderna pops: Tale of two pharma stocks

  • 📰 YahooFinanceCA
  • ⏱ Reading Time:
  • 43 sec. here
  • 6 min. at publisher
  • 📊 Quality Score:
  • News: 34%
  • Publisher: 63%

Novo Nordisk News

Moderna,Earnings Reports,Pharmaceutical Stocks

Pharmaceutical stocks Novo Nordisk (NVO) and Moderna (MRNA) are trending in opposite directions following their earnings reports. Despite topping Wall...

Galen Weston calls Loblaw boycott 'misguided criticism', says grocer not responsible for higher prices

"Their frustration is understandable, but this kind of expectation betrays a misunderstanding of what's actually driving food prices higher in this country."This dividend stock is near 52-week highs, but still down from all-time highs, with a highly valuable P/E ratio you won't want to miss. The post 1 Magnificent Dividend Stock That’s Down 21% and Trading at a Once-in-a-Decade Valuation appeared first on The Motley Fool Canada.The Canadian dollar strengthened against its U.S.

-- Traders on Wall Street cheered on Wednesday when Federal Reserve Chair Jerome Powell signaled he didn’t see oncoming interest-rate hikes despite inflationary pressures. The celebration didn’t last long.Most Read from BloombergUS and Saudis Near Defense Pact Meant to Reshape Middle EastJerome Powell Offered Markets a Reprieve.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 47. in AU
 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Australia Australia Latest News, Australia Australia Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Novo Nordisk raises 2024 outlook as company races to boost output of Wegovy weight-loss drugNovo Nordisk reported better-than-expected first-quarter profits on Thursday as it looks to fend off competition from rival Eli Lilly
Source: globeandmail - 🏆 5. / 92 Read more »